http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105859762-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-027 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2016-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105859762-B |
| titleOfInvention | Adjacent carborane derivative, its preparation method and application and prepare the intermediate of this neighbour's carborane derivative |
| abstract | The invention discloses a kind of adjacent carborane derivative, its preparation method and application and prepare the intermediate of this neighbour's carborane derivative.The structure of described adjacent carborane derivative is as shown in formula IV, shown in the structure of described intermediate such as formula (V).Present invention also offers the application of described adjacent carborane derivative.The present invention is with adjacent carborane as starting material, carry out a series of lithiumation, electrophilic, necleophilic reaction finally gives the adjacent carborane derivative with hydrophilic radical, carry out a series of cancer subsequently, test neoplastic cell measures and finds, this compounds specific can be gathered in tumor cell, and has hypotoxicity. |
| priorityDate | 2016-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 129.